Ethical dilemmas in pediatric endocrinology: Growth hormone for short normal children

R. Macklin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Ethical questions surrounding the administration of synthetic growth hormone (GH) to short normal children can be grouped into the following four categories: 1) appropriateness of medical treatment when no disease or biological deficiency is present; 2) how to proceed in the face of ambiguity or uncertainty of research results; 3) difficulty in weighing the risks and benefits of treatment; and 4) who should decide? This article seeks to determine whether GH administration to normal short children is properly considered an 'enhancement', and, if so, whether such treatment would be ethically wrong.

Original languageEnglish (US)
Pages (from-to)1349-1352
Number of pages4
JournalJournal of Pediatric Endocrinology and Metabolism
Volume13
Issue numberSUPPL. 6
StatePublished - 2000

Fingerprint

Endocrinology
Growth Hormone
Pediatrics
Uncertainty
Therapeutics
Research

Keywords

  • Enhancement
  • Ethical considerations
  • Growth hormone
  • Moral
  • Short children

ASJC Scopus subject areas

  • Endocrinology
  • Pediatrics, Perinatology, and Child Health

Cite this

Ethical dilemmas in pediatric endocrinology : Growth hormone for short normal children. / Macklin, R.

In: Journal of Pediatric Endocrinology and Metabolism, Vol. 13, No. SUPPL. 6, 2000, p. 1349-1352.

Research output: Contribution to journalArticle

@article{7f52b19bad944de88a55e4ac4f4bc7a4,
title = "Ethical dilemmas in pediatric endocrinology: Growth hormone for short normal children",
abstract = "Ethical questions surrounding the administration of synthetic growth hormone (GH) to short normal children can be grouped into the following four categories: 1) appropriateness of medical treatment when no disease or biological deficiency is present; 2) how to proceed in the face of ambiguity or uncertainty of research results; 3) difficulty in weighing the risks and benefits of treatment; and 4) who should decide? This article seeks to determine whether GH administration to normal short children is properly considered an 'enhancement', and, if so, whether such treatment would be ethically wrong.",
keywords = "Enhancement, Ethical considerations, Growth hormone, Moral, Short children",
author = "R. Macklin",
year = "2000",
language = "English (US)",
volume = "13",
pages = "1349--1352",
journal = "Journal of Pediatric Endocrinology and Metabolism",
issn = "0334-018X",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "SUPPL. 6",

}

TY - JOUR

T1 - Ethical dilemmas in pediatric endocrinology

T2 - Growth hormone for short normal children

AU - Macklin, R.

PY - 2000

Y1 - 2000

N2 - Ethical questions surrounding the administration of synthetic growth hormone (GH) to short normal children can be grouped into the following four categories: 1) appropriateness of medical treatment when no disease or biological deficiency is present; 2) how to proceed in the face of ambiguity or uncertainty of research results; 3) difficulty in weighing the risks and benefits of treatment; and 4) who should decide? This article seeks to determine whether GH administration to normal short children is properly considered an 'enhancement', and, if so, whether such treatment would be ethically wrong.

AB - Ethical questions surrounding the administration of synthetic growth hormone (GH) to short normal children can be grouped into the following four categories: 1) appropriateness of medical treatment when no disease or biological deficiency is present; 2) how to proceed in the face of ambiguity or uncertainty of research results; 3) difficulty in weighing the risks and benefits of treatment; and 4) who should decide? This article seeks to determine whether GH administration to normal short children is properly considered an 'enhancement', and, if so, whether such treatment would be ethically wrong.

KW - Enhancement

KW - Ethical considerations

KW - Growth hormone

KW - Moral

KW - Short children

UR - http://www.scopus.com/inward/record.url?scp=0034522406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034522406&partnerID=8YFLogxK

M3 - Article

C2 - 11202208

AN - SCOPUS:0034522406

VL - 13

SP - 1349

EP - 1352

JO - Journal of Pediatric Endocrinology and Metabolism

JF - Journal of Pediatric Endocrinology and Metabolism

SN - 0334-018X

IS - SUPPL. 6

ER -